By comparing IL-17RC silencing-induced functional and intracellular signaling changes in two different tumor cell lines, we have explicitly demonstrated a novel molecular mechanism underlying IL-17RC-controlled tumor-specific proliferation (see Figure 7 for our model). The gene discussed is IL17RC; the disease is neoplasm.